{
    "2018-03-02": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Wall Street More Optimistic about Johnson & Johnson after 4Q17",
                "features": {
                    "keywords": [
                        "Wall Street",
                        "Optimistic",
                        "Johnson & Johnson",
                        "4Q17"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-05",
                "original_text": "Sanofi’s Generics and Consumer Healthcare Portfolios in 4Q17",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Generics",
                        "Consumer Healthcare",
                        "Portfolios",
                        "4Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-02-06",
                "original_text": "Sanofi’s Established Prescription Products in 4Q17",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Prescription Products",
                        "Established",
                        "4Q17"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Novartis Shareholders Approve All Resolutions At AGM - Quick Facts",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Shareholders",
                        "Approve",
                        "Resolutions",
                        "AGM"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}